Mitsubishi Tanabe Pharma gets US rights to AnGes' Phase III Collategene; later expands rights
- Gene Therapy, Cell Therapy
- Large Molecule
- R+D and Marketing-Licensing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.